Diagnos (TSE:ADK) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
DIAGNOS Inc., a Canadian AI-driven healthcare technology company, announced the successful re-election of its board directors and the re-appointment of its auditor following its recent shareholders meeting. Additionally, the company gained shareholder approval for an increase in the stock option plan by 2,000,000 shares, subject to TSX Venture acceptance.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.
